Role of ERK activation in cisplatin-induced apoptosis in OK renal epithelial cells

被引:148
|
作者
Kim, YK [1 ]
Kim, HJ
Kwon, CH
Kim, JH
Woo, JS
Jung, JS
Kim, JM
机构
[1] Pusan Natl Univ, Coll Med, Dept Physiol, Pusan 602739, South Korea
[2] Dong A Univ, Coll Med, Dept Anat, Pusan, South Korea
关键词
cisplatin; apoptosis; ERK1/2; activation; mitochondrial dysfunction; opossum kidney cells;
D O I
10.1002/jat.1081
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cisplatin induces apoptosis in a variety of cell types. However, the signaling pathway of cisplatin-induced lapoptosis in renal epithelial cells,is poorly understood. The present study was undertaken to determine the role of the extracellular signal-regulated kinase (ERK) in cisplatin-induced apoptosis of renal epithelial cells using opossum kidney cells. Cisplatin at 50 gm induced apoptosis in a time-dependent manner. Cisplatin treatment caused sustained activation of ERK1/2, which was prevented by PD98059 and U0126, inhibitors of ERK1/2 upstream kinase MEK1/2. Transient transfection of cells with constitutive active MEK1 increased the cisplatin-induced apoptosis, whereas that with a dominant-negative mutant of MEK1 decreased it. Cisplatin induced an increase in Bax expression, mitochondrial membrane depolarization, mitochondrial cytochrome c release and caspase-3 activation, and these changes were prevented by the MEK inhibitor. These results suggested that (1) the ERK1/2 activation is required for the cisplatin-induced apoptosis of renal epithelial cells; and (2) ERK1/2 mediates the mitochondria-dependent apoptotic signaling by acting upstream of Bax expression. Copyright (C) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:374 / 382
页数:11
相关论文
共 50 条
  • [21] Cisplatin-induced apoptosis is enhanced by hypoxia and by inhibition of mitochondria in renal collecting duct cells
    Schwerdt, G
    Freudinger, R
    Schuster, C
    Weber, F
    Thews, O
    Gekle, M
    TOXICOLOGICAL SCIENCES, 2005, 85 (01) : 735 - 742
  • [22] PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells
    Hueber, PA
    Waters, P
    Clarke, P
    Eccles, M
    Goodyer, P
    KIDNEY INTERNATIONAL, 2006, 69 (07) : 1139 - 1145
  • [23] Curcumin counteracts cisplatin-induced nephrotoxicity by preventing renal tubular cell apoptosis
    Topcu-Tarladacalisir, Yeter
    Sapmaz-Metin, Melike
    Karaca, Turan
    RENAL FAILURE, 2016, 38 (10) : 1741 - 1748
  • [24] Cisplatin-induced apoptosis in human promyelocytic leukemia cells
    Previati, Maurizio
    Lanzoni, Irene
    Corbacella, Elisa
    Magosso, Sara
    Guaran, Valeria
    Martini, Alessandro
    Capitani, Silvano
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 18 (03) : 511 - 516
  • [25] Cisplatin-induced apoptosis in cultures of human Schwann cells
    Jirsova, K
    Mandys, V
    Gispen, WH
    Bär, PR
    NEUROSCIENCE LETTERS, 2006, 392 (1-2) : 22 - 26
  • [26] Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells
    Noda, S
    Yoshimura, SI
    Sawada, M
    Naganawa, T
    Iwama, T
    Nakashima, S
    Sakai, N
    JOURNAL OF NEURO-ONCOLOGY, 2001, 52 (01) : 11 - 21
  • [27] Role of Ceramide During Cisplatin-induced Apoptosis in C6 Glioma Cells
    Shinji Noda
    Shin-ichi Yoshimura
    Motoshi Sawada
    Takashi Naganawa
    Toru Iwama
    Shigeru Nakashima
    Noboru Sakai
    Journal of Neuro-Oncology, 2001, 52 : 11 - 21
  • [28] Role of apoptosis in cisplatin-induced toxicity in the renal epithelial cell line LLC-PK1 -: Implication of the functions of apical membranes
    Okuda, M
    Masaki, K
    Fukatsu, S
    Hashimoto, Y
    Inui, K
    BIOCHEMICAL PHARMACOLOGY, 2000, 59 (02) : 195 - 201
  • [29] Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy
    Hong Liu
    Liu-bao Gu
    Yue Tu
    Hao Hu
    Yan-ru Huang
    Wei Sun
    Acta Pharmacologica Sinica, 2016, 37 : 235 - 245
  • [30] Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy
    Liu, Hong
    Gu, Liu-bao
    Tu, Yue
    Hu, Hao
    Huang, Yan-ru
    Sun, Wei
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (02) : 235 - 245